Loading clinical trials...
Loading clinical trials...
Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET
Conditions
Interventions
LUTATHERA® (Lutetium Lu 177 dotatate)
Locations
4
United States
Children's Hospital Colorado
Aurora, Colorado, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
November 21, 2022
Primary Completion Date
November 1, 2028
Completion Date
November 1, 2033
Last Updated
April 13, 2026
NCT03340506
NCT05212272
NCT05839379
NCT04655404
NCT05940493
NCT02523014
Lead Sponsor
Nationwide Children's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions